Facial Injectables Market By Product Type (Dermal Fillers, Botox), By End-user (Hospitals, Dermatology Centers, Physician's Office), By Region (North America, Europe, Asia Pacific, RoW) – Global Forecast up to 2025

Global Facial Injectables Market by Product Types (Dermal

Fillers, Botox), By End-users (Hospitals, Dermatology Centers,

Physician’s Office), and By Regions (North America, Europe,

Asia Pacific, and Rest of the World) – Global Forecast up to

2025

This market research report includes a detailed segmentation of the global facial

injectables market by product types (dermal fillers and Botox), by end-users

(hospitals, dermatology centers, and physician’s office), and by regions (North

America, Europe, APAC, and RoW).

Research Overview

IHR Insights predicts that the global facial injectables market will grow at a

CAGR of 10.81% during the forecast period 2019–2025. Facial injectables refer to the

aesthetic treatment of the skin that results in a more youthful look. There are a

variety of aesthetic procedures performed, including those used to treat skin

conditions (deep lines & wrinkles), change the contours of jaw or lips, scars &

depressions in the skin resulting from acne, congenital or injury imperfections, etc.

Dermal fillers and Botox are the top-leading products used to treat these skin

conditions. Dermal fillers offer treatment to face, neck, and hands, thereby resulting

in a smooth, fuller, and more youthful look. Dermal fillers are increasingly being

adopted due to immediate positive results, which have become popular globally.

There are temporary fillers that are absorbed by the body and are classified into

collagen-based fillers, hyaluronic acid-based fillers, calcium hydroxylapatite, and

poly-L-lactic acid. These have provisional results and are used every 4–6 months.

Permanent fillers are made of polymethylmethacrylate (PMMA), which are not

absorbed by the body. ArteFill is among the most common brand used as

permanent fillers.

An increase in beauty consciousness, growing awareness about facial injections,

increasing demand for non-surgical & minimally invasive cosmetic surgeries, and

anticipated launch of new products are expected to drive the market growth during

the forecast period. The market is also witnessing few emerging trends, including

increase in demand for combination treatments, rise in medical tourism, and

increasing disposable income, which will drive the market at a significant pace

during the forecast period. The facial injectables market in Brazil, India, China, and

Russia is also expected to grow at a rapid pace during the forecast period as the

adoption of cosmetic procedures in these countries is high.

Most of the vendors are focusing on evidence-based clinical results for the

development and advancement of the product. The advancements in technology,

the emergence of innovative products with the adoption of minimally invasive

procedures, and the demand for facial injectables for the treatment of various skin

conditions are driving the market growth.

•Advancementsininjectableneedleshaveresultedintheemergenceofmolecularchangesandalterationinviscoelasticpropertiesofnew-generationfillersusingthehybridmatrixorVycrosstechnologieswith3Dcross-linkingtogiveGprimefillers•IncreaseindemandforcombinationtreatmentsOpportunities

Challenges•Highcostofinjectablesandfrequencyofadoptionarechallenges•Complicationsandrisksassociatedwithfacialinjectablesmayleadtoadverseeffects,i.e.,stroke,blindness,visionimpairment,orevendeathinrarecases

Trends•Increaseinthepreferenceforminimallyinvasiveproceduresindermatologyisduetoaffordabilityandeffectivenessofthetreatment•Increaseindisposableincomehasledtotheincreasedadoptionrateexponentiallyoverthepastyears

Market dynamics

•Thetrendofselfies,especiallyindevelopedcountries(US,France,Germany,Italy),hascontributedtotheincreaseinthenumberofcosmeticsurgeriesasmanypeoplearebecominghyper-awareoftheirimages•Cosmeticsurgeriesarenolongerawomen-specificdomain;thereisanincreaseintheadoptionofcosmeticsurgeriesfrommenindevelopedcountries•Botoxinjectionsareupby36%since2014CAGR: 10.81% (2019–2025)

> 47% market shareKey Highlights

The market is fueled by innovation and new technological techniques & procedures.

The presence of large, small, and local vendors in the market has led to high

competition among them. The global facial injectables market is dominated by

Allergan, Galderma, Merz Pharma, and Ipsen. These vendors are consistently

increasing their footprint in the market; regional vendors are finding it more difficult

to compete with larger players, especially on quality, pricing, market reach, and

financial resources. Further, they are expanding their inorganic growth by acquiring

regional or local players.

Segmentation by Product Types:

 Dermal Fillers

 Botox

The market players compete on various factors: price, availability, brand, and

variety. Price is set to become a major base for competition among players

specializing in certain products to gain an edge in the market. The companies with

better-skilled workforce and financial resources are able to manufacture products

that may render competitors merchandise non-competitive even before they are

launched. This makes it difficult for the latter to recover R&D and commercialization

costs. As a result, vendors must develop new products and stay abreast of emerging

market trends that influence their product lines.

Segmentation by End-users:

 Hospitals

 Dermatology Centers

 Physician’s Office

In 2018, dermatology centers gained the highest share in the facial injectables

market with a large volume of cosmetic treatments globally.

Segmentation by Regions:

 North America

 Europe

 Asia Pacific

 RoW